Cognex Corporation $CGNX Shares Sold by GW&K Investment Management LLC

GW&K Investment Management LLC trimmed its stake in Cognex Corporation (NASDAQ:CGNX) by 6.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,522,767 shares of the scientific and technical instruments company’s stock after selling 99,430 shares during the quarter. GW&K Investment Management LLC’s holdings in Cognex were worth $54,790,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. REAP Financial Group LLC purchased a new position in Cognex during the third quarter worth approximately $27,000. CIBC Private Wealth Group LLC grew its stake in shares of Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after buying an additional 327 shares during the period. Geneos Wealth Management Inc. increased its holdings in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of Cognex by 207.6% in the 3rd quarter. Smartleaf Asset Management LLC now owns 935 shares of the scientific and technical instruments company’s stock worth $43,000 after buying an additional 631 shares during the period. Finally, Rothschild Investment LLC raised its position in shares of Cognex by 21,060.0% in the 3rd quarter. Rothschild Investment LLC now owns 1,058 shares of the scientific and technical instruments company’s stock worth $48,000 after buying an additional 1,053 shares during the period. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity

In other news, insider Mark Fennell sold 64,873 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the transaction, the insider directly owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. The trade was a 85.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Darren Marc Long sold 20,252 shares of the company’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares of the company’s stock, valued at $264,696.60. This trade represents a 83.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 224,847 shares of company stock worth $14,975,098 over the last 90 days. Company insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. UBS Group set a $75.00 price target on Cognex in a research report on Tuesday, May 26th. Weiss Ratings restated a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. DA Davidson set a $62.00 target price on Cognex and gave the stock a “neutral” rating in a report on Thursday, May 14th. Sanford C. Bernstein reissued an “outperform” rating and set a $75.00 target price on shares of Cognex in a research report on Thursday, May 7th. Finally, Stephens raised their price target on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.43.

Cognex Price Performance

NASDAQ:CGNX opened at $61.32 on Wednesday. The business’s 50-day moving average is $58.89 and its two-hundred day moving average is $48.91. The firm has a market capitalization of $10.20 billion, a PE ratio of 73.00 and a beta of 1.52. Cognex Corporation has a 12 month low of $29.22 and a 12 month high of $71.90.

Cognex (NASDAQ:CGNX) last posted its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. The business had revenue of $268.44 million during the quarter, compared to analyst estimates of $245.98 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company’s revenue for the quarter was up 24.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Equities analysts anticipate that Cognex Corporation will post 1.41 EPS for the current year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st were given a $0.085 dividend. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $0.34 annualized dividend and a yield of 0.6%. Cognex’s dividend payout ratio (DPR) is 40.48%.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.